分子細胞遺伝学市場規模、シェア、成長分析、製品別、技術別、用途別、エンドユーザー別、地域別 - 産業別予測、2024～2031年

分子細胞遺伝学の世界市場規模は、2022年に23億7,000万米ドルと評価され、2023年の25億8,000万米ドルから2031年には50億2,000万米ドルに成長し、予測期間中（2024-2031年）にCAGR 8.7％で成長する見通しです。

分子生物学と細胞遺伝学を統合した分子細胞遺伝学の分野は、正常なヒト細胞には46本の染色体が存在するという基礎知識に基づき、健康な細胞とがん性の細胞を区別する上で重要な役割を果たしています。この分野は、蛍光in situハイブリダイゼーション（FISH）のような技術を通じて染色体異常に焦点を当て、脳腫瘍や血液悪性腫瘍を含む様々ながんの検出と治療を助ける。この市場は、がんの有病率の増加、遺伝性疾患、高齢化によって著しい成長を遂げています。加えて、標的療法の普及や、試薬やソフトウェアの改良を含むヘルスケア技術の進歩が、診断精度の向上に寄与しています。生物医学研究への投資の増加は市場拡大をさらに後押しし、分子細胞遺伝学の堅調な将来を予測しています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2023年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 技術の進歩
• 規制情勢
• ケーススタディ
• 特許分析

分子細胞遺伝学市場規模：製品別

• 市場概要
• キットと試薬
  • 検査キット
  • プローブ
  • 蛍光親和性試薬
  • その他のキットと試薬
• 機器
• 消耗品
• ソフトウェアとサービス

分子細胞遺伝学市場規模：技術別

• 市場概要
• 比較ゲノムハイブリダイゼーション
  • アレイベースの比較ゲノムハイブリダイゼーション
  • 標準比較ゲノムハイブリダイゼーション
• 蛍光in-situハイブリダイゼーション
• クロモジェニックインサイチューハイブリダイゼーション
• 核型分析
  • スペクトル
  • バーチャル
• その他のテクニック

分子細胞遺伝学市場規模：用途別

• 市場概要
• 遺伝性疾患
• がん
• パーソナライズ医療
• その他の用途

分子細胞遺伝学市場規模：エンドユーザー別

• 市場概要
• 臨床調査室
• 病院と病理検査室
• 学術調査機関
• 製薬・バイオテクノロジー企業
• その他のエンドユーザー

分子細胞遺伝学市場規模：地域別

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2023年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2023年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2021-2023）

主要企業プロファイル

• F. Hoffmann-la roche ltd.
• Agilent technologies, inc.
• Abbott laboratories
• Thermo fisher scientific, inc.
• Illumina inc.
• Revvity
• Pacific biosciences
• Bio-rad laboratories, inc.
• Bio-techne corporation
• Genedx
• Bioview
• Applied spectral imaging, inc.
• Cytotest inc.
• Kromatid, inc.
• Genial genetic solutions ltd.
• Cytognomix, inc.
• Metasystems
• Scigene
• Biomodal
• Biocare medical

結論と推奨事項

Global Molecular Cytogenetics Market size was valued at USD 2.37 billion in 2022 and is poised to grow from USD 2.58 billion in 2023 to USD 5.02 billion by 2031, growing at a CAGR of 8.7% during the forecast period (2024-2031).

The field of molecular cytogenetics, integrating molecular biology and cytogenetics, plays a crucial role in distinguishing healthy cells from cancerous ones, stemming from the foundational knowledge that normal human cells contain 46 chromosomes. This discipline aids in the detection and treatment of various cancers, including brain tumors and hematological malignancies, focusing on chromosomal abnormalities through techniques like fluorescence in situ hybridization (FISH). The market is witnessing significant growth, driven by the increasing prevalence of cancer, genetic disorders, and an aging population. Additionally, the rising adoption of targeted therapies and advancements in healthcare technology, including improved reagents and software, contribute to enhanced diagnostic accuracy. Increased investment in biomedical research further propels market expansion, projecting a robust future for molecular cytogenetics.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Molecular Cytogenetics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Molecular Cytogenetics Market Segmental Analysis

Global Molecular Cytogenetics Market is segmented by product, technique, application, end user and region. Based on product, the market is segmented into kits & reagents, instruments, consumables and software & services. Based on technique, the market is segmented into comparative genomic hybridization, fluorescence in-situ hybridization, chromogenic in-situ hybridization, karyotyping and other techniques. Based on application, the market is segmented into genetic disorders, cancer, personalized medicine and other applications. Based on end user, the market is segmented into clinical & research laboratories, hospitals & path labs, academic research institutes, pharmaceutical & biotechnology companies and other end users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Molecular Cytogenetics Market

The Global Molecular Cytogenetics market is poised for significant growth, driven primarily by the rising incidence of cancer cases worldwide. This field, which merges the principles of cytogenetics with molecular biology, is expected to see increased adoption as more healthcare professionals recognize its efficacy in diagnosing and understanding various cancers. The growing prevalence of cancer not only highlights the need for advanced diagnostic tools but also encourages investments and research in molecular cytogenetics, thereby fueling market expansion. As a result, the demand for molecular cytogenetics will likely continue to rise throughout the projected period.

Restraints in the Global Molecular Cytogenetics Market

The Global Molecular Cytogenetics market faces several significant constraints that could impede its growth. Stringent regulatory requirements pose a challenge, as compliance can be both complex and time-consuming. Additionally, unfavorable reimbursement policies from insurance providers significantly limit access to molecular diagnostic tests, which are essential for early detection of genetic conditions. The high costs associated with these tests, typically ranging around USD 300 each, also create a financial barrier for many patients and healthcare providers. Collectively, these factors contribute to a restrictive environment that hampers the expansion of the molecular cytogenetics market.

Market Trends of the Global Molecular Cytogenetics Market

The Global Molecular Cytogenetics market is witnessing a robust growth trend, driven primarily by the increasing emphasis on personalized medicine and advanced therapeutic options in oncology. As genomic understanding becomes crucial for effective cancer care-enabling precise diagnostics, tailored treatment plans, and improved survival predictions-the demand for molecular cytogenetic techniques is surging. This market is expected to expand significantly as healthcare providers leverage these technologies for detailed cancer analysis and individualized therapies. As pharmacotherapy and bespoke treatment alternatives gain prominence, the market is poised for lucrative expansion throughout the forecast period, underlining the pivotal role of molecular cytogenetics in modern oncology.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape
• Case Studies
• Patent Analysis

Global Molecular Cytogenetics Market Size by Product & CAGR (2024-2031)

• Market Overview
• Kits & Reagents
  • Testing Kits
  • Probes
  • Fluorescent Affinity Reagents
  • Other Kits & Reagents
• Instruments
• Consumables
• Software & Services

Global Molecular Cytogenetics Market Size by Technique & CAGR (2024-2031)

• Market Overview
• Comparative Genomic Hybridization
  • Array-Based Comparative Genomic Hybridization
  • Standard Comparative Genomic Hybridization
• Fluorescence In-Situ Hybridization
• Chromogenic In-Situ Hybridization
• Karyotyping
  • Spectral
  • Virtual
• Other Techniques

Global Molecular Cytogenetics Market Size by Application & CAGR (2024-2031)

• Market Overview
• Genetic Disorders
• Cancer
• Personalized Medicine
• Other Applications

Global Molecular Cytogenetics Market Size by End User & CAGR (2024-2031)

• Market Overview
• Clinical & Research Laboratories
• Hospitals & Path Labs
• Academic Research Institutes
• Pharmaceutical & Biotechnology Companies
• Other End Users

Global Molecular Cytogenetics Market Size & CAGR (2024-2031)

• North America (Product, Technique, Application, End User)
  • USA
  • Canada
• Europe (Product, Technique, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Technique, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Technique, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Technique, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• F. Hoffmann-la roche ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent technologies, inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo fisher scientific, inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Revvity
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pacific biosciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-rad laboratories, inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-techne corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genedx
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioview
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Applied spectral imaging, inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cytotest inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kromatid, inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genial genetic solutions ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cytognomix, inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Metasystems
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Scigene
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biomodal
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biocare medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations